NEW YORK (GenomeWeb) – CombiMatrix today said that the New York State Department of Health conditionally approved the CombiSNP Array for Pregnancy Loss for testing on fresh and formalin-fixed, paraffin-embedded patient samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.